Global Eubiotics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Eubiotics Market is presumed to reach the market size of nearly USD 16.99 BN by 2030 from USD 8.12 BN in 2022 with a CAGR of 8.55% under the study period of 2023 - 2030. Regarding volume, the market was calculated XX Units in 2022 and forecast to touch XX Units by 2030 with a CAGR of XX% during 2023 - 2030.

Eubiotics is a term used to describe substances or techniques that promote the balance and well-being of microorganisms in the digestive system of animals. It refers to the use of feed additives, such as probiotics, prebiotics, organic acids, and enzymes, to improve the health and performance of animals. Eubiotics are used in animal husbandry to reduce the use of antibiotics and other chemical additives in feed, as they provide a natural and safe alternative. They are also used to improve animal health, welfare, and productivity, as well as to reduce the incidence of diseases and the need for veterinary interventions.

Market Dynamics:

The growing demand for meat and animal products worldwide is driving the demand for eubiotics in animal feed. Eubiotics help improve animal health and productivity, which leads to better quality and quantity of meat and dairy products. The restriction on antibiotic growth promoters' usage in animal feed in many countries has led to the increased use of eubiotics as a natural alternative to improve animal health and performance. The increasing awareness among consumers and animal welfare organizations about the use of antibiotics in animal feed and its potential impact on animal health and welfare are driving the demand for eubiotics. The rising concerns about food safety and quality are driving the demand for eubiotics in animal feed. Eubiotics are considered safe and natural alternatives to antibiotics, and their use can improve the quality and safety of meat and animal products. The development of new and advanced technologies in the production of eubiotics, such as microencapsulation and nanotechnology, is driving the growth of the eubiotics market. The rising demand for meat and animal products in the growing economies of China, India, and Brazil is driving the demand for eubiotics in animal feed. The increasing demand from these regions is expected to drive the growth of the global eubiotics market in the coming years.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of eubiotics. The growth and trends of Eubiotics Industry provide a holistic approach to this study.

Market Segmentation:

This section of the eubiotics market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Probiotics
Prebiotics
Essential Oils
Organic Acids

By Form

Solid
Liquid

By Livestock

Poultry
Swine
Ruminants
Aquatic Animals

By Function

Nutrition & Gut Health
Yield
Immunity
Production

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Eubiotics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the eubiotics market include DSM, Novozymes, Kemin Industries Inc., Roquette Freres, FrieslandCampina, Neospark Drugs and Chemicals Private Limited, ASAHI GROUP HOLDINGS Ltd., Lesaffre, MSPrebiotics Inc., ADM, Lallemand Inc., BEHN MEYER, NOVUS INTERNATIONAL, BENEO, Yara, Cargill Incorporated, BASF SE, Chr. Hansen Holding A/S, ADDCON GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

Product Code: VMR112110645

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . EUBIOTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Form
- 3.7.3 Market Attractiveness Analysis By Livestock
- 3.7.4 Market Attractiveness Analysis By Function
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL EUBIOTICS MARKET ANALYSIS BY TYPE

6.1 Overview by Type
6.2 Historical and Forecast Data
6.3 Analysis by Type
6.4 Probiotics Historic and Forecast Sales by Regions
6.5 Prebiotics Historic and Forecast Sales by Regions
6.6 Essential Oils Historic and Forecast Sales by Regions
6.7 Organic Acids Historic and Forecast Sales by Regions

7 . GLOBAL EUBIOTICS MARKET ANALYSIS BY FORM

7.1 Overview by Form
7.2 Historical and Forecast Data
7.3 Analysis by Form
7.4 Solid Historic and Forecast Sales by Regions
7.5 Liquid Historic and Forecast Sales by Regions

8 . GLOBAL EUBIOTICS MARKET ANALYSIS BY LIVESTOCK

8.1 Overview by Livestock
8.2 Historical and Forecast Data
8.3 Analysis by Livestock
8.4 Poultry Historic and Forecast Sales by Regions
8.5 Swine Historic and Forecast Sales by Regions
8.6 Ruminants Historic and Forecast Sales by Regions
8.7 Aquatic Animals Historic and Forecast Sales by Regions

9 . GLOBAL EUBIOTICS MARKET ANALYSIS BY FUNCTION

9.1 Overview by Function
9.2 Historical and Forecast Data
9.3 Analysis by Function
9.4 Nutrition & Gut Health Historic and Forecast Sales by Regions
9.5 Yield Historic and Forecast Sales by Regions
9.6 Immunity Historic and Forecast Sales by Regions
9.7 Production Historic and Forecast Sales by Regions

10 . GLOBAL EUBIOTICS MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Data Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Data Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Data Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Data Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Data Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE EUBIOTICS COMPANIES

11.1. Eubiotics Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12 . COMPANY PROFILES OF EUBIOTICS INDUSTRY

12.1. Company Share Analysis
12.2. Market Concentration Rate
12.3. DSM
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
12.4. Novozymes
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
12.5. Kemin Industries Inc.
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
12.6. Roquette Freres
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
12.7. FrieslandCampina
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
12.8. Neospark Drugs and Chemicals Private Limited
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
12.9. ASAHI GROUP HOLDINGS Ltd.
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
12.10. Lesaffre
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
12.11. MSPrebiotics Inc.
- 12.11.1. Company Overview
- 12.11.2. Company Revenue
- 12.11.3. Products
- 12.11.4. Recent Developments
12.12. ADM
- 12.12.1. Company Overview
- 12.12.2. Company Revenue
- 12.12.3. Products
- 12.12.4. Recent Developments
12.13. Lallemand Inc.
- 12.13.1. Company Overview
- 12.13.2. Company Revenue
- 12.13.3. Products
- 12.13.4. Recent Developments
12.14. BEHN MEYER
- 12.14.1. Company Overview
- 12.14.2. Company Revenue
- 12.14.3. Products
- 12.14.4. Recent Developments
12.15. NOVUS INTERNATIONAL
- 12.15.1. Company Overview
- 12.15.2. Company Revenue
- 12.15.3. Products
- 12.15.4. Recent Developments
12.16. BENEO
- 12.16.1. Company Overview
- 12.16.2. Company Revenue
- 12.16.3. Products
- 12.16.4. Recent Developments
12.17. Yara
- 12.17.1. Company Overview
- 12.17.2. Company Revenue
- 12.17.3. Products
- 12.17.4. Recent Developments
12.18. Cargill Incorporated
- 12.18.1. Company Overview
- 12.18.2. Company Revenue
- 12.18.3. Products
- 12.18.4. Recent Developments
12.19. BASF SE
- 12.19.1. Company Overview
- 12.19.2. Company Revenue
- 12.19.3. Products
- 12.19.4. Recent Developments
12.20. Chr. Hansen Holding A/S
- 12.20.1. Company Overview
- 12.20.2. Company Revenue
- 12.20.3. Products
- 12.20.4. Recent Developments
12.21. ADDCON GmbH
- 12.21.1. Company Overview
- 12.21.2. Company Revenue
- 12.21.3. Products
- 12.21.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies